ScholarIQanswers from OpenAlex

Early Real-World Descriptive Findings on Tolvaptan-Treated Patients with Autosomal Dominant Polycystic Kidney Disease in the United States

PaperCitations, authors & open-access status

Early Real-World Descriptive Findings on Tolvaptan-Treated Patients with Autosomal Dominant Polycystic Kidney Disease in the United States is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Early Real-World Descriptive Findings on Tolvaptan-Treated Patients with Autosomal Dominant Polycystic Kidney Disease in the United States have?

ScholarIQcitation count

Early Real-World Descriptive Findings on Tolvaptan-Treated Patients with Autosomal Dominant Polycystic Kidney Disease in the United States has 0 citations in the OpenAlex counts ScholarIQ stores.

When was Early Real-World Descriptive Findings on Tolvaptan-Treated Patients with Autosomal Dominant Polycystic Kidney Disease in the United States published?

ScholarIQyear

Early Real-World Descriptive Findings on Tolvaptan-Treated Patients with Autosomal Dominant Polycystic Kidney Disease in the United States has 2020 year in the ScholarIQ index.

What is the open-access status of Early Real-World Descriptive Findings on Tolvaptan-Treated Patients with Autosomal Dominant Polycystic Kidney Disease in the United States?

ScholarIQoa status

Early Real-World Descriptive Findings on Tolvaptan-Treated Patients with Autosomal Dominant Polycystic Kidney Disease in the United States has closed oa status in the ScholarIQ index.

What is the DOI of Early Real-World Descriptive Findings on Tolvaptan-Treated Patients with Autosomal Dominant Polycystic Kidney Disease in the United States?

ScholarIQdoi

The DOI for Early Real-World Descriptive Findings on Tolvaptan-Treated Patients with Autosomal Dominant Polycystic Kidney Disease in the United States is on the source record.

What is the OpenAlex record for Early Real-World Descriptive Findings on Tolvaptan-Treated Patients with Autosomal Dominant Polycystic Kidney Disease in the United States?

ScholarIQopenalex

The OpenAlex for Early Real-World Descriptive Findings on Tolvaptan-Treated Patients with Autosomal Dominant Polycystic Kidney Disease in the United States is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial